BILLS-118hr9942ih.pdf

05:49 Oct 22 later than 180 days later than six months OCTOBER 8, 2024 2025 8 days every six months one year 2034 2 days 1996 2 months later than one year the 10 years preceding fiscal year 2026 later than 270 days seven years 180 days later 180 days the period of fiscal years

the ‘‘Valley Fever SESSION H. R. 9942

the United States States the United States of America United States

the National Valley National Valley

SEC Control and Prevention the Centers for Disease the Advisory Committee Centers for Disease Control and Prevention the National Institutes of Health Advisory Committee the Department of Health State Human Services Centers for Disease Control the Committee on Energy and Commerce the ‘National Valley Fever Federal the Public Health Service Congress National Institutes Defense House of Representa- the Centers for Disease Control the Federal Government TIONAL sonally National Institutes of Health the National Vital Statistics the National Institutes of the National Center for Health the National Valley Research and Development Authority Advisory the ‘Advisory Committee’ Health and Human Services sory Committee Senate APPROPRIATIONS THE HOUSE OF REPRESENTATIVES Vaccine Development Drug Administration the National Valley Fever Registry

OBERNOLTE COSTA TOKUDA STANTON DUARTE SCHWEIKERT

vaccine valley manufacturing licensing national strategy support development coordinator expedite expert enactment section strategy website department development stakeholders heads